Skip to main content
Premium Trial:

Request an Annual Quote

Manchester, UK, Center to Use $69M for Genetics and Translational Research

NEW YORK (GenomeWeb News) – A new government-funded research center in Manchester, UK, plans to set its sights on genetics and translational research that would lead to predictive tests for fetal problems and pregnancy complications, government and media sources in the UK said this week.
 
The Biomedical Research Center will include research from Central Manchester and Manchester Children’s University Hospitals, NHS Trust, and the University of Manchester, according to the British Secretary of Health.
 
The Manchester BRC will receive £7.4 million ($14.7 million) per year over four years for a total of around £35 million from the Department of Health, and it has applied for as much as £10 million per year in external grants from the North West Developmental Agency, the Manchester Evening News reported today. 
 
"The new Biomedical Research Centre in Manchester will strengthen our drive to put the UK at the forefront of vital health research and contribute to the nation's international competitiveness as a major component of our knowledge economy," Health Secretary Alan Johnson said in a statement.
 
The Manchester BRC joins several other Biomedical Research Centers in London, Oxford, Cambridge, Liverpool, and Newcastle.
 
The UK has allocated £50 million for all of the BRCs during the first year of operation and £100 million per year over the next four years. The amount allocated to each center is determined by the scale and nature of the research activity that it conducts and the anticipated impact of that activity, according to the UK’s National Institute for Health Research.
 
In addition to developing a predictive test for pregnancy complications, the Manchester BRC will use genetic technologies to improve diagnosis and treatment in other areas including sudden cardiac death, developmental disease, disadvantaged populations, and inflammatory bowel disease.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.